Medical workers remain desperate to find an edge with each spike of coronavirus cases. Doctors and nurses worry about running out of hospital beds, especially in the Intensive Care Unit, where the most serious cases of COVID-19 are treated. A team of data scientists at Stanford, however, has found a way to boost ICU capacity by as much as 25%.
“I would have imagined that people who were sent home with oxygen would have a higher chance of getting complications. That did not turn out to be the case,” said Dr. Nigam Shah, a data scientist and a professor of Medical Bioinformatics at Stanford University.
E-Mail
COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine.
The findings identify new links between the course of the disease and a patient s immune response. They also raise concerns about whether people can be re-infected, whether antibody tests to detect prior infection may underestimate the breadth of the pandemic and whether vaccinations may need to be repeated at regular intervals to maintain a protective immune response. This is one of the most comprehensive studies to date of the antibody immune response to SARS-CoV-2 in people across the entire spectrum of disease severity, from asymptomatic to fatal, said Scott Boyd, MD, PhD, associate professor of pathology. We assessed multiple time points and sample types, and also analyzed levels of viral RNA in patient nasopharyngeal